Literature DB >> 11322507

Growth hormone secretagogue receptor family members and ligands.

R G Smith1, R Leonard, A R Bailey, O Palyha, S Feighner, C Tan, K K Mckee, S S Pong, P Griffin, A Howard.   

Abstract

We have previously reported the cloning and characterization of a new orphan G-protein-coupled receptor (GPC-R), the growth hormone secretagogue receptor (GHS-R), and shown that this receptor mediates the activity of the growth hormone-releasing peptides (GHRPs) and nonpeptide ligands such as L-692,429 and MK-0677. Because the GHS-R obviously does not belong to any of the known GPC-R subfamilies, we searched for GHS-R family members by screening a human genomic library using low-stringency hybridization and screening a Pufferfish genomic library. The Pufferfish was selected because of its compact genome. From the human genomic library, a homolog, GPR38, with 52% identity to the GHS-R was isolated. From the Pufferfish library, three family members were isolated. The Pufferfish gene having 58% identity to the GHS-R, on expression in HEK293 cells, was activated with GHRP-6 and MK-0677. These results indicate that the GHS-R has been conserved for at least 400 million years and that the Pufferfish genome is appropriate for isolation of GHS-R family members. In our search for endogenous ligands for the orphan receptors GHS-R and GPR38, we showed that adenosine is a partial agonist of the GHS-R and that motilin is the endogenous ligand for GPR38. We also confirmed that the endogenous ligand ghrelin is a full agonist of the GHS-R.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322507     DOI: 10.1385/ENDO:14:1:009

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.

Authors:  A Tivesten; E Bollano; K Caidahl; V Kujacic; X Y Sun; T Hedner; A Hjalmarson; B A Bengtsson; J Isgaard
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

2.  Receptor for motilin identified in the human gastrointestinal system.

Authors:  S D Feighner; C P Tan; K K McKee; O C Palyha; D L Hreniuk; S S Pong; C P Austin; D Figueroa; D MacNeil; M A Cascieri; R Nargund; R Bakshi; M Abramovitz; R Stocco; S Kargman; G O'Neill; L H Van Der Ploeg; J Evans; A A Patchett; R G Smith; A D Howard
Journal:  Science       Date:  1999-06-25       Impact factor: 47.728

3.  Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors.

Authors:  K K McKee; C P Tan; O C Palyha; J Liu; S D Feighner; D L Hreniuk; R G Smith; A D Howard; L H Van der Ploeg
Journal:  Genomics       Date:  1997-12-15       Impact factor: 5.736

4.  Cardiac effects of hexarelin in hypopituitary adults.

Authors:  G Bisi; V Podio; M R Valetto; F Broglio; G Bertuccio; G Aimaretti; E Pelosi; G Del Rio; G Muccioli; H Ong; M F Boghen; R Deghenghi; E Ghigo
Journal:  Eur J Pharmacol       Date:  1999-09-17       Impact factor: 4.432

5.  Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.

Authors:  V De Gennaro Colonna; G Rossoni; M Bernareggi; E E Müller; F Berti
Journal:  Cardiologia       Date:  1997-11

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Comparative sequence analysis of the human and pufferfish Huntington's disease genes.

Authors:  S Baxendale; S Abdulla; G Elgar; D Buck; M Berks; G Micklem; R Durbin; G Bates; S Brenner; S Beck
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.

Authors:  G Rossoni; V De Gennaro Colonna; M Bernareggi; G L Polvani; E E Müller; F Berti
Journal:  J Cardiovasc Pharmacol       Date:  1998-08       Impact factor: 3.105

9.  Expression of tyrosine hydroxylase in cultured brain cells: stimulation with an extractable pituitary cytotropic factor.

Authors:  J C Porter; W Kedzierski; N Aguila-Mansilla; B A Jorquera
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

10.  Purification and identification of pituitary cytotropic factor.

Authors:  J C Porter; C F Ijames; T C Wang; S P Markey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  22 in total

1.  Recombinant adenovirus-mediated expression of GHS-R1a in HEK 293 cells.

Authors:  Li Liu; Hua-Min Xu; Hong Jiang; Jun Wang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  Ghrelin increases memory consolidation through hippocampal mechanisms dependent on glutamate release and NR2B-subunits of the NMDA receptor.

Authors:  Marisa S Ghersi; L A Gabach; F Buteler; A A Vilcaes; H B Schiöth; M F Perez; S R de Barioglio
Journal:  Psychopharmacology (Berl)       Date:  2014-12-04       Impact factor: 4.530

3.  Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilization.

Authors:  Paul J Currie; Catherine S John; Marjorie L Nicholson; Colin D Chapman; Katherine E Loera
Journal:  Pharmacol Biochem Behav       Date:  2010-06-02       Impact factor: 3.533

Review 4.  Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome.

Authors:  Roberta Giordano; Andreea Picu; Fabio Broglio; Lorenza Bonelli; Matteo Baldi; Rita Berardelli; Ezio Ghigo; Emanuela Arvat
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

Authors:  M Gálfi; M Radács; Zs Molnár; I Budai; G Tóth; A Pósa; K Kupai; Z Szalai; R Szabó; H A Molnár; J Gardi; Ferenc A László; Cs Varga
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

6.  Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer.

Authors:  Steffen Helmling; Christian Maasch; Dirk Eulberg; Klaus Buchner; Werner Schröder; Christian Lange; Stefan Vonhoff; Britta Wlotzka; Matthias H Tschöp; Stefan Rosewicz; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

7.  Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications.

Authors:  Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  Int J Pept       Date:  2010-02-09

8.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

Review 9.  Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation.

Authors:  Omero Alessandro Paoluzi; Del Vecchio Giovanna Blanco; Roberta Caruso; Ivan Monteleone; Giovanni Monteleone; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways.

Authors:  Talat Waseem; Mark Duxbury; Hiromichi Ito; Stanley W Ashley; Malcolm K Robinson
Journal:  Surgery       Date:  2007-12-27       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.